Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
Times Cited: 21
Times Cited: 21
Times Cited
Times Co-cited
Similarity
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
61
The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
57
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Jean-Claude Tardif, Piotr Ponikowski, Thomas Kahan. Eur Heart J 2009
Jean-Claude Tardif, Piotr Ponikowski, Thomas Kahan. Eur Heart J 2009
57
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
52
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
42
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
42
Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
42
Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
38
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Kim Fox, Ian Ford, Ph Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Eur Heart J 2009
Kim Fox, Ian Ford, Ph Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Eur Heart J 2009
38
Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
38
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.
G Heusch. Br J Pharmacol 2008
G Heusch. Br J Pharmacol 2008
33
Coronary microvascular dysfunction: an update.
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
33
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Witold Ruzyllo, Michal Tendera, Ian Ford, Kim M Fox. Drugs 2007
Witold Ruzyllo, Michal Tendera, Ian Ford, Kim M Fox. Drugs 2007
28
Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia.
F Maranta, L Tondi, E Agricola, A Margonato, O Rimoldi, Paolo G Camici. Basic Res Cardiol 2015
F Maranta, L Tondi, E Agricola, A Margonato, O Rimoldi, Paolo G Camici. Basic Res Cardiol 2015
50
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
28
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
Gerd Heusch, Andreas Skyschally, Petra Gres, Patrick van Caster, Dustin Schilawa, Rainer Schulz. Eur Heart J 2008
Gerd Heusch, Andreas Skyschally, Petra Gres, Patrick van Caster, Dustin Schilawa, Rainer Schulz. Eur Heart J 2008
28
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Jeffrey S Borer, Kim Fox, Patrice Jaillon, Guy Lerebours. Circulation 2003
Jeffrey S Borer, Kim Fox, Patrice Jaillon, Guy Lerebours. Circulation 2003
28
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
28
Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
28
Pleiotropic, heart rate-independent cardioprotection by ivabradine.
P Kleinbongard, N Gedik, P Witting, B Freedman, N Klöcker, G Heusch. Br J Pharmacol 2015
P Kleinbongard, N Gedik, P Witting, B Freedman, N Klöcker, G Heusch. Br J Pharmacol 2015
23
Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
Dario DiFrancesco, John A Camm. Drugs 2004
Dario DiFrancesco, John A Camm. Drugs 2004
23
alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans.
G Heusch, D Baumgart, P Camici, W Chilian, L Gregorini, O Hess, C Indolfi, O Rimoldi. Circulation 2000
G Heusch, D Baumgart, P Camici, W Chilian, L Gregorini, O Hess, C Indolfi, O Rimoldi. Circulation 2000
23
Vascular pathophysiology in response to increased heart rate.
Florian Custodis, Stephan H Schirmer, Magnus Baumhäkel, Gerd Heusch, Michael Böhm, Ulrich Laufs. J Am Coll Cardiol 2010
Florian Custodis, Stephan H Schirmer, Magnus Baumhäkel, Gerd Heusch, Michael Böhm, Ulrich Laufs. J Am Coll Cardiol 2010
23
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Sripal Bangalore, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A Eagle, Shinya Goto, E Magnus Ohman, Christopher P Cannon, Sidney C Smith, Uwe Zeymer,[...]. JAMA 2012
Sripal Bangalore, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A Eagle, Shinya Goto, E Magnus Ohman, Christopher P Cannon, Sidney C Smith, Uwe Zeymer,[...]. JAMA 2012
23
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
23
Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease.
Ercole Tagliamonte, Fausto Rigo, Teresa Cirillo, Costantino Astarita, Gaetano Quaranta, Umberto Marinelli, Archimede Caruso, Carlo Romano, Nicola Capuano. Echocardiography 2015
Ercole Tagliamonte, Fausto Rigo, Teresa Cirillo, Costantino Astarita, Gaetano Quaranta, Umberto Marinelli, Archimede Caruso, Carlo Romano, Nicola Capuano. Echocardiography 2015
23
Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
Lorenzo López-Bescós, Slavomira Filipova, Ramón Martos. Cardiology 2007
Lorenzo López-Bescós, Slavomira Filipova, Ramón Martos. Cardiology 2007
19
Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion.
G Heusch, N Yoshimoto. Pflugers Arch 1983
G Heusch, N Yoshimoto. Pflugers Arch 1983
19
Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
19
Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
40
Optimal medical therapy with or without PCI for stable coronary disease.
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
19
Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.
Stephan H Schirmer, Achim Degen, Magnus Baumhäkel, Florian Custodis, Lisa Schuh, Michael Kohlhaas, Erik Friedrich, Ferdinand Bahlmann, Reinhard Kappl, Christoph Maack,[...]. Eur Heart J 2012
Stephan H Schirmer, Achim Degen, Magnus Baumhäkel, Florian Custodis, Lisa Schuh, Michael Kohlhaas, Erik Friedrich, Ferdinand Bahlmann, Reinhard Kappl, Christoph Maack,[...]. Eur Heart J 2012
19
I f inhibition with ivabradine : electrophysiological effects and safety.
Irina Savelieva, A John Camm. Drug Saf 2008
Irina Savelieva, A John Camm. Drug Saf 2008
19
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. Eur Heart J 2015
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. Eur Heart J 2015
19
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Lancet 2008
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Lancet 2008
19
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Stephan D Fihn, Julius M Gardin, Jonathan Abrams, Kathleen Berra, James C Blankenship, Apostolos P Dallas, Pamela S Douglas, Joanne M Foody, Thomas C Gerber, Alan L Hinderliter,[...]. Circulation 2012
Stephan D Fihn, Julius M Gardin, Jonathan Abrams, Kathleen Berra, James C Blankenship, Apostolos P Dallas, Pamela S Douglas, Joanne M Foody, Thomas C Gerber, Alan L Hinderliter,[...]. Circulation 2012
19
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
19
Angina at 1 year after myocardial infarction: prevalence and associated findings.
Thomas M Maddox, Kimberly J Reid, John A Spertus, Murray Mittleman, Harlan M Krumholz, Susmita Parashar, P Michael Ho, John S Rumsfeld. Arch Intern Med 2008
Thomas M Maddox, Kimberly J Reid, John A Spertus, Murray Mittleman, Harlan M Krumholz, Susmita Parashar, P Michael Ho, John S Rumsfeld. Arch Intern Med 2008
19
Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Angelo Villano, Antonino Di Franco, Roberto Nerla, Alfonso Sestito, Pierpaolo Tarzia, Priscilla Lamendola, Antonio Di Monaco, Filippo Maria Sarullo, Gaetano Antonio Lanza, Filippo Crea. Am J Cardiol 2013
Angelo Villano, Antonino Di Franco, Roberto Nerla, Alfonso Sestito, Pierpaolo Tarzia, Priscilla Lamendola, Antonio Di Monaco, Filippo Maria Sarullo, Gaetano Antonio Lanza, Filippo Crea. Am J Cardiol 2013
19
Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies.
Karl Werdan, Stefan Perings, Ralf Köster, Malte Kelm, Thomas Meinertz, Georg Stöckl, Ursula Müller-Werdan. Cardiology 2016
Karl Werdan, Stefan Perings, Ralf Köster, Malte Kelm, Thomas Meinertz, Georg Stöckl, Ursula Müller-Werdan. Cardiology 2016
36
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Puja K Mehta, Pavel Goykhman, Louise E J Thomson, Chrisandra Shufelt, Janet Wei, Yuching Yang, Edward Gill, Margo Minissian, Leslee J Shaw, Piotr J Slomka,[...]. JACC Cardiovasc Imaging 2011
Puja K Mehta, Pavel Goykhman, Louise E J Thomson, Chrisandra Shufelt, Janet Wei, Yuching Yang, Edward Gill, Margo Minissian, Leslee J Shaw, Piotr J Slomka,[...]. JACC Cardiovasc Imaging 2011
19
Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
19
Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
19
Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice.
A Drouin, M-E Gendron, E Thorin, M-A Gillis, F Mahlberg-Gaudin, J-C Tardif. Br J Pharmacol 2008
A Drouin, M-E Gendron, E Thorin, M-A Gillis, F Mahlberg-Gaudin, J-C Tardif. Br J Pharmacol 2008
14
Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Xavier Monnet, Patrice Colin, Bijan Ghaleh, Luc Hittinger, Jean-François Giudicelli, Alain Berdeaux. Eur Heart J 2004
Xavier Monnet, Patrice Colin, Bijan Ghaleh, Luc Hittinger, Jean-François Giudicelli, Alain Berdeaux. Eur Heart J 2004
14
Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs.
B D Guth, G Heusch, R Seitelberger, J Ross. Circ Res 1987
B D Guth, G Heusch, R Seitelberger, J Ross. Circ Res 1987
14
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries.
D Baumgart, M Haude, G Görge, F Liu, J Ge, C Grosse-Eggebrecht, R Erbel, G Heusch. Circulation 1999
D Baumgart, M Haude, G Görge, F Liu, J Ge, C Grosse-Eggebrecht, R Erbel, G Heusch. Circulation 1999
14
Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise.
R Seitelberger, B D Guth, G Heusch, J D Lee, K Katayama, J Ross. Circ Res 1988
R Seitelberger, B D Guth, G Heusch, J D Lee, K Katayama, J Ross. Circ Res 1988
14
Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
14
β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.
Charlotte Andersson, David Shilane, Alan S Go, Tara I Chang, Dhruv Kazi, Matthew D Solomon, Derek B Boothroyd, Mark A Hlatky. J Am Coll Cardiol 2014
Charlotte Andersson, David Shilane, Alan S Go, Tara I Chang, Dhruv Kazi, Matthew D Solomon, Derek B Boothroyd, Mark A Hlatky. J Am Coll Cardiol 2014
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.